Aim: In the present study, a therapeutic trial was conducted to assess comparative efficacy of crystalloid plus colloid and crystalloid intravenous infusions alone as fluid therapy in dogs suffering from hemorrhagic gastroenteritis (HGE).
Introduction
In small animal clinics, presentation of patients with vomiting and diarrhea are a day-to-day affair. Hemorrhagic gastroenteritis (HGE), particularly in young dogs is a life-threatening condition due to loss of body fluid and electrolytes along with blood leading to a massive reduction in circulatory volume. This contributes to high mortality associated with the underlying condition and also with concurrent septic complications. Fluid therapy in these patients is essential to correct hypovolemic, dehydration, acid-base imbalances and serum electrolyte abnormalities [1] .
Use of various crystalloids in such diseases has been practiced since long. Now-a-days colloid solutions are gaining interest in fluid resuscitation of critically ill patients as they produce immediate circulatory volume expansion, retain longer in the vascular space than crystalloids and have lower risk of tissue edema due to their high molecular weight [2] . Though, relative effectiveness of colloids as compared to crystalloid fluids in reducing mortality is still debatable, colloids are used alone or in combination widely as are more effective in maintaining colloidal osmotic pressure (COP) [3] . Use of colloidal infusions may provide a more effective fluid management protocol in the crisis of HGE.
Thus, in the present study, a therapeutic trial was conducted to assess comparative efficacy of crystalloid plus colloid and crystalloid intravenous infusions alone as fluid therapy in dogs suffering from HGE.
Materials and Methods

Ethical approval
All clinical cases were examined and treated as per standard examination and treatment procedure.
Selection of animals
A therapeutic trial was conducted on randomly selected 20 cases of HGE manifesting bloody diarrhea which were presented at Small Animal Clinics, Teaching Veterinary Clinical Services Complex (TVCC), Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Ludhiana, Punjab. All the selected animals were suffering from frequent vomiting and bloody diarrhea. On examination by skin turgidity test, moistness of mucous membrane, capillary refilling time (CRT), mentation of the animals and hemato-biochemical tests, moderate to severe dehydration was observed. A group of eight clinically healthy animals were considered as control for this study.
Study design
The cases were divided into two study groups each consisting of 10 cases. In one group of animals buffered isotonic crystalloid fluids (Ringer's lactate, 5% dextrose normal saline) were prescribed and in other, colloidal infusion solution along with crystalloids. Amount of crystalloid fluid to be instituted was calculated as, total fluid deficit (in litres) = body weight (kg)×% dehydration. In the other group of animals, colloid was given after initial stabilization with balanced crystalloid infusion. The total volume of crystalloid solutions were infused twice daily in all the cases and were reduced by 25% in the first group of dogs along with other supportive therapies. Colloidal infusion used in this study was 3.5% degraded gelatin polypeptides cross-linked via urea bridges (polygelatin), administered at the rate of 10-20 ml/kg bwt./day [2] with an infusion rate of 50-60 drops/min. The animals were observed closely for any adverse reaction while administration of the colloid and vital signs were monitored. Symptomatic therapies including, antiemetics (metoclopramide hydrochloride and prochlorperazine maleate), H 2 -antagonist (ranitidine), coagulants (adenochrome monosemicarbazide, ethamsylate) and antibiotic regimen consisting of amikacin sulphate (10 mg/kg bwt., i/v or i/m, BD), ampicillin (20-25 mg/kg bwt., i/v or i/m, BD), metronidazole (15-20 mg/kg bwt., i/v or i/m, BD) were provided to both group of animals [4] . To understand the outcome of therapies administered, clinical and hemato-biochemical parameters were noted in both groups of patients on the day of the presentation and day 6. Hemato-biochemical parameters of the control group dogs were considered as a reference to compare with the after treatment values of diseased animals for assessing improvement towards normalization.
Statistical methodology
To assess significant heterogeneity, a comparison of hemato-biochemical parameters was done between before-and after therapy-data, that is, on day 0 and day 6, within each group, by paired-t-test at 95% confidence level. The outcomes of both the treatment groups were evaluated on day 6 with respect to the control group by one-way analysis of variance at 95% confidence level with Tukey honestly significantly different and Duncan post-hoc comparison tests.
Results
Selected dogs were of different breeds, age ranging from 3 to 6 months and of both sexes. They were suffering from frequent vomiting and hematochezia, inappetance or complete anorexia and were recumbent with depressed mentation. On clinical examination of the 20 cases, they were observed to have high rectal temperature (average 103.8°F) and moderate to severe anemia. Skin remained tented for more than 2 s with sticky gum mucous membrane and CRT more than 2-3 s corresponding to moderate to severe (>8%) dehydration in the patients. Control animals were of different breeds and of age group 3-5 months. They had normal rectal temperature (average 101.8°F), pale pink conjunctival mucosa, skin turgidity test and CRT within 2 s, normal color and consistency of feces with normal playful activity and appetite. They were regularly dewormed and were vaccinated. Hematobiochemical examination of affected cases revealed percent packed cell volume (PCV): <0.35 L/L and serum biochemistry showed total serum protein: <55 g/L and serum albumin: <26 g/L prior to administration of any therapy, whereas in control group of dogs the values of these parameters were within normal range, that is, 0.409±0.011 L/L, 64±2 g/L and 32±1 g/L respectively.
Hemato-biochemical studies of the patients treated with Combination I therapy: (n=10)
Anemia was an obvious consequence of HGE along with hypovolemia. Clinically moderate to severe anemia was evident on presentation in all of the cases. On 6 th day, average hemoglobin concentration was found 104±14 g/L from 116.3±5.4 g/L of day 0, though clinical improvement was noticed (Table-1) . No significant variation was found in mean PCV while average total erythrocyte count (TEC) was reduced on 6 th day significantly (5.76±0.24 to 4.78±0.32×10 12 g/L) after the therapy. Mean total leucocyte count (TLC) was found 6.262±2.657×10 9 /L before administering therapy that increased to 10,623±1,832×10 9 /L after the treatment. In differential leucocytes count, significant (p<0.05) changes were observed, such as percent lymphocytes and platelet count reduced, whereas, neutrophil percentage increased, on day 6 th in comparison to day 0 (Table-1) .
On 0 day, biochemical examination revealed, mean total protein concentration of 48±3 g/L, serum albumin of 23±2 g/L and globulin 26±2 g/L and on 6 th day 37±4.5 g/L, 18.7±3.6 g/L and 18.7±1.5 g/L respectively ( Table-1 ). Hypoproteinemia and hypoalbuminemia seemed to aggravate further on 6 th day. Serum globulin reduced significantly on 6 th day as compared to day zero (Table-1 ). Average albumin to globulin ratio was 0.89±0.09 and 0.99±0.16 respectively on zero and 6 th day. Average total bilirubin and alkaline phosphatase (ALKP) concentrations were increased whereas, average serum alanine transaminase (ALT) concentration decreased on day 6 as compared to day 0. Serum blood urea nitrogen (BUN) concentration was observed to reduce considerably on 6 th day (0.499±0.164 mmol/L) in comparison to that on the 0 day (3.927±0.357 mmol/L), whereas, serum concentration of creatinine increased slightly on 6 th day. Failed to sustain, three dogs died during the treatment while in one case the owner requested for euthanization.
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Hemato-biochemical studies of the patients treated with Combination II therapy: (n=10)
The average hemoglobin concentration was 121.8±5.3 g/L on presentation which significantly differed on 6 th day to 105.2±4.8 g/L after administering combination II therapy (Table-1 ). However, PCV and TEC were not found altered significantly after the therapy. Mean TLC was found 9.630±2.672×10 9 /L on presentation and later became 14.233±3.721×10 9 /L. No significant change was observed in percent neutrophil, lymphocytes and eosinophil and platelet count ( Table-1) .
On presentation, biochemical examination revealed, mean total protein concentration of 48.2±3.7 g/L, serum albumin of 20±1.1 g/L and globulin 28.2±3.1 g/L and on 6 th day 48.4±5.2 g/L, 19.7±2.8 g/L and 28.7±2.9 g/L respectively ( Table-1) . However, there was no significant change in any of the serum biochemical parameters between day 0 and day 6. Average total bilirubin, ALT and ALKP concentration were reduced, indicating improvement of liver function parameters. Concentrations of BUN and creatinine were observed to reduce on 6 th day after the treatment. The alterations in total protein, liver and renal function tests observed on day 6 th indicated recovery as compared to day 0, except serum albumin. Three cases succumbed during the treatment and in one case owner did not report back.
Comparison of hemato-biochemical parameters of the patients treated with Combination I and Combination II therapy with control group After 6 th day of this therapeutic trial, hemato-biochemical parameters of Combination I and II were compared with control animal group which revealed that leucogram (TLC, percent neutrophil, percent lymphocytes) of both the trial groups were improved nearer to control group though hemoglobin and PCV of both the trial groups remained lower than the control animals. Mean total protein and albumin of the trial groups were still lower than the control group and average serum globulin values of Combination I group was lower than that of Combination II group as well as a control group. Accordingly albumin: globulin ratio also altered and was found lower in Combination II group in comparison to other two groups (Table-2 ).
All the animals were clinically assessed on regular basis and during treatment improvement of the general condition were noticed with increased activity, reduced frequency and volume of vomiting and diarrhea and loss of fluid and blood through feces. Gradual reduction of rectal temperature to an average 102.2°F, pale to pinkish conjunctival mucous membrane, improved hydration status with CRT ≤2 s and skin turgidity test <2 s were observed. Their recovery towards normalization was evident by their interest in food intake when provided with liquid to soft consistency food. Clinical recovery was observed in an average of 4.84±0.31 days in animals treated with Combination I while in 6.5±0.34 days in Combination II group of dogs.
Discussion
Animals suffering from bloody diarrhoea and vomiting have hypovolemia along with hypoproteinemia and hypoalbuminemia leading to reduction of COP [1, 4] of intravascular fluid. Administration of crystalloids alone in combating dehydration in such patients pose risk of low cardiovascular pressure, pooling of water in microvasculature of gut, bacterial translocation, pulmonary and cerebral edema [5] [6] [7] [8] . Colloidal infusions should be considered in hypovolemic patients when total protein concentration is <45 g/L [1] . Hypoalbuminemia <20 g/L increases mortality in critically ill animals [4] . Colloids provide COP support in vasculature [7] and are effective in diseases with increased microvascular permeability, such as sepsis, systemic inflammatory response syndrome, vascular deficits, pancreatitis, burn, canine parvovirus enteritis etc., [2, 4] , in low volume resuscitation protocols [2] , and can be useful in cases of hypercoagulability, such as viral enteritis [1, 9] as they prolong coagulation time. Colloid administration in conjunction with isotonic crystalloids can provide a balance between both type of therapies [2, 8] with reduction of volume of crystalloids by 25-60% to compensate fluid deficit [10, 11] . In this present study, colloidal infusion was administered in boluses at the dose rate of 10-20 ml/kg/day at which chances of adverse effects on coagulation and renal profile are known to be minimum [8, 10, 12, 13] . Colloidal solutions based on 0.9% saline such as, dextran 70, hydroxyethylstarch, can result in hypercholremic metabolic acidosis [14, 3] . Newer colloids with balanced electrolytes reduce this complication. Low molecular weight polygelatin 3.5% exerting COP of 28 mm of Hg [15] and osmolarity of 301 combined with 145 mmol/L of NaCl, 5.1 mmol/L of K + , 6.25 mmol/L of Ca +2 electolytes and pH: 7.3±0.3 was used in this present study. Low molecular weight and presence of calcium in this colloidal infusion have less risk of coagulopathy [16, 3] .
In the present study, clinical assessment of hypovolemia was done on the basis of subjective physical examination variables such as rectal temperature, CRT, mucous membrane, skin fold test, activity and mental status of the animals [8] and hemato-biochemical tests. Prior to the commencement of the therapies, patients had moderate dehydration (8%), hypoproteinemia and hypoalbuminemia as compared to the clinically healthy animals considered as control. Comparative higher hemoglobin concentration in presence of low PCV on presentation in HGE cases could be due to hemoconcentration that improved later with correction of hypovolemia in both group of animals after therapy. The changes in hydration status and effects of drugs on vital organs of the patients might account for the alterations of parameters of liver and renal panel as observed on day 6 th in comparison to day 0. After administering Combination I, improvement was observed in the condition with increased activity and appetite, while faster clinical recovery became apparent on successive days than in Combination II group. This was also evident by the fact that, clinical recovery was found to be faster by an average of 1.67 days in the animals treated with Combination I than the ones treated with Combination II. However, there was no other noticeable difference in the hematological and biochemical parameters of Combination I and Combination II therapies. No adverse reactions were noticed during colloidal infusion. Mortality during the treatment had little significance between the two treatment groups. Benefits of crystalloids over colloid solutions or vice-e-versa remain debatable till date [17] [18] [19] [20] . Similar, randomized controlled trials on fluid resuscitation and risk of mortality on use of synthetic colloids in critically ill patients as compared with crystalloids were done previously but no statistical evidence of heterogeneity in the trial results of hemato-biochemical variables and length of hospital stay were found [17, 18] . Most of the meta-analyses regarding inclusion of colloids in fluid resuscitation protocols and recommendations of administration of various colloids are designed for human-patients. Only limited veterinary specific data on effects of various colloids given alone or in combination with isotonic crystalloids on animal physiology, their safety and efficacy in fluid management of critically ill animal patients are available [4] . In this present study, effects of both the fluid therapies on hemodynamic and serological parameters of the animals were ambivalent. However, colloidal infusion might have played an important role in clinical recovery of the animals suffering from gastrointestinal emergencies. Thus the use of different colloids in alleviation of various diseases of animals seeks special attention and need further studies.
